Childhood chronic inflammatory demyelinating polyneuropathy: an overview of 10 cases in the modern era.
Chronic inflammatory demyelinating polyneuropathy is a rare condition in children. In this article, we report our experience in the management of 10 cases of childhood chronic inflammatory demyelinating polyneuropathy in a single center, in the era of contrast-enhanced magnetic resonance imaging (MRI), genetic microarray, and chronic inflammatory demyelinating polyneuropathy disease activity status. Robust neurophysiologic abnormalities were present in all cases and both MRI and lumbar puncture were useful adjuncts in diagnosis. Genetic microarray is a simple technique useful in excluding the most common hereditary demyelinating neuropathy. Intravenous immunoglobulin was an effective first-line therapy in most cases, with refractory cases responding to corticosteroids and rituximab. We found the chronic inflammatory demyelinating polyneuropathy disease activity status useful for assessing outcome at final follow-up, whereas the modified Rankin score was better for assessing peak motor disability.
1Department of Neurology, The Royal Children's Hospital, Melbourne, Australia.
Tyson L
TL
Ware
Andrew J
AJ
Kornberg
M Victoria
MV
Rodriguez-Casero
Monique M
MM
Ryan
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003863:Depression / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009431:Neural Conduction / Q000502:physiology; D059906:Neuroimaging; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D012189:Retrospective Studies; D013116:Spinal Cord / Q000473:pathology
demyelinating; magnetic resonance imaging (MRI); nerve conduction study; neuropathy; polyneuropathy